Oral nicotinamide reduces serum phosphorus, increases HDL, and induces thrombocytopenia in hemodialysis patients: a double-blind randomized clinical trial Shahbazian, Heshmatolah Shahbazian, Zafar Mohtashami, Azita Zafar Mohtashami, Ghorbani, Ali Ghorbani, Abbaspour, Mohammad Reza Abbaspour, Belladi Musavi, Sayed Seifolah Belladi Musavi, Fatemeh Hayati, Ghollam Reza Lashkarara

Phosphorus binders: preferences of patients on haemodialysis and its impact on treatment compliance and phosphorus control María Dolores Arenas, Tamara Malek, Fernando Álvarez-Ude, María Teresa Gil, Analía Moledous, Abilio Reig-Ferrer

Safety and effectiveness of sucroferric oxyhydroxide in Spanish patients on dialysis: sub-analysis of the VERIFIE study María Auxiliadora Bajo, Francisco Ríos-Moreno, Maria Dolores Arenas, Ramón Jesús Devesa-Such, Maria Jose Molina-Higueras, Margarita Delgado, Pablo Molina, Nuria García-Fernández, Alejandro Martin-Malo, Roser Peiró-Jordán, Jorge Cannata-Andia, Ángel Luis Martín-De Francisco